Gut microbiota and intestinal FXR mediate the clinical benefits of metformin
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Gut microbiota and intestinal FXR mediate the clinical benefits of metformin have?
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin has 1,022 citations in the OpenAlex counts ScholarIQ stores.
When was Gut microbiota and intestinal FXR mediate the clinical benefits of metformin published?
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin has 2018 year in the ScholarIQ index.
What is the open-access status of Gut microbiota and intestinal FXR mediate the clinical benefits of metformin?
Gut microbiota and intestinal FXR mediate the clinical benefits of metformin has green oa status in the ScholarIQ index.
What is the DOI of Gut microbiota and intestinal FXR mediate the clinical benefits of metformin?
The DOI for Gut microbiota and intestinal FXR mediate the clinical benefits of metformin is on the source record.
What is the PMID of Gut microbiota and intestinal FXR mediate the clinical benefits of metformin?
The PMID for Gut microbiota and intestinal FXR mediate the clinical benefits of metformin is on the source record.
What is the OpenAlex record for Gut microbiota and intestinal FXR mediate the clinical benefits of metformin?
The OpenAlex for Gut microbiota and intestinal FXR mediate the clinical benefits of metformin is on the source record.